Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Navidea Biopharmaceuticals Downgraded by Zacks Investment Research

 

Navidea Biopharmaceuticals Downgraded by Zacks Investment Research

2015-11-26 07:50:52| Biotech - Topix.net

According to Zacks, "Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek , AZD4694 and RIGScan .

Tags: research investment downgraded zacks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

06.07 Tropical Storm Beryl Public Advisory Number 33 06.07 Summary for Tropical Storm Beryl (AT2/AL022024) 06.07 Tropical Storm Beryl Public Advisory Number 32A 06.07 Summary for Tropical Storm Beryl (AT2/AL022024) 06.07 Eastern North Pacific Tropical Weather Outlook 06.07 Atlantic Tropical Weather Outlook 06.07 Axalta Schedules Second-Quarter 2024 Earnings Conference Call 06.07 Tropical Storm Beryl Potential Storm Surge Flooding Map More »